Societies

Abstract submission system open for the ESMO Gynaecological Cancers 2025

European Society for Medical Oncology/LinkedIn

Jan 18, 2025, 23:03

Abstract submission system open for the ESMO Gynaecological Cancers 2025

European Society for Medical Oncology (ESMO), shared a post on LinkedIn:

“ESMO Gynaecological Cancers 2025: Share your knowledge with an international audience of gynaecological oncology experts and collaborate with fellow researchers to forge synergies that can lead to new discoveries and advancements.

Abstract submission system open – deadline 3rd April 2025.

During this event, delegates will have the chance to attend sessions covering:

Practice-changing progress in the treatment of patients with gynaecological cancers.
Recent developments in therapies integrating PARP inhibitors, targeted agents, and ADCs for managing patients with ovarian cancer.
State-of-the-art in diagnosis and management of cervical and endometrial cancers.
Bench to bedside research perspectives in gynaecological oncology.
Novel therapeutic strategies for rare gynaecological cancers.”

More posts featuring European Society for Medical Oncology.

A. Oaknin B. Monk cancer cervical cancers endometrial cancers European Society for Medical Oncology Gynaecological oncology Gynaeological Cancers N.Colombo. OncoDaily Oncology Ovarian Cancer PARP inhibitors researcher therapies

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology